Abstract
At the outset, it is important to define some terminologies. A “nuclear weapon detonation” is propelled, not by conventional chemical reactions, but rather by an atomic chain reaction, in which a massive amount of energy is released in a confined space in an instant of time. This energy release manifests in several different forms, such as initial nuclear radiation, residual nuclear radiation, thermal radiation, and blast and shock waves (1). Because of the massive explosive power of even small nuclear weapons, large-scale destruction of buildings and human deaths are likely. In contrast, a “radiological dispersal device” (RDD), commonly referred to as a “dirty bomb,” has less impact as a weapon; radioactive materials are dispersed through the use of chemical explosives. The RDD is designed mainly to cause chronic radiation injuries and create delayed radiation sickness, panic, and fear among military and civilian populations. To predict the level of exposure or injury an RDD might cause is difficult, because radiation dose depends on many factors, such as the physical and chemical forms of the radioactive material, the size and type of explosive, and proximity to the blast. Most likely, the most severe, immediate effects of a dirty bomb would be the disruption from the evacuation, the fear and panic in the general population, the subsequent cleanup of contaminated property, and the associated economic costs. The long-term health effects of an RDD may not be immediately predictable but clearly might produce chronic injuries and late-arising pathologies.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
The views expressed in this chapter are solely those of the authors and do not necessarily reflect the official policy or position of the Department of the Army, Department of Defense, or the U.S. government.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Glasstone S, Dolan PJ. The effects of nuclear weapons. Department of the Army Pamphlet, No. 50–3. Headquarters, Department of the Army, Washington, DC, 1977.
Inadequate control of world’s radioactive sources. Available at http://www.iaea.org/worldatom/Press/Prelease/2002/prn0209.shtml.
Levi MA, Kelly HC. Weapons of mass disruption. Sci Am 2002;287:77–81.
Alt AL, Forcino CD, Walker RI. Nuclear events and their consequences. In: Walker RI, Gerveny TJ, eds. Text Book of Military Medicine: Medical Consequences of Nuclear Warfare. TMM Publications, Office of the Surgeon General, Falls Church, VA, 1989, pp. 1–14.
Hall E J. Radiology for radiologists. JB Lippincott, Philadelphia, 1994.
Kumar KS, Vaishnav YN, Weiss JF. Radioprotection by antioxidant enzymes and enzyme mimetics. Pharmacol Ther 1988;39:301–309.
Goldman M, Rosenblatt LS, Book SA. Lifetime radiation effects research in animals: an overview of the status and philosophy of studies at University of California-Davis Laboratory for Energy-Related Health Research. In: Thompson RC, Mahaffey JA, eds. Life-Span Radiation Effects Studies in Animals: What Can They Tell Us? CONF-830951. Office of Scientific and Technical Information, US Department of Energy, Washington, DC, 1986, pp. 53–65.
Fritz TE, Seed TM, Tolle DV, Lombard LS. Late effects of protracted whole-body irradiation of beagles by cobalt-60 gamma rays. In: Thompson RC, Mahaffey JA, eds. Life-Span Radiation Effects Studies in Animals: What Can They Tell Us? CONF-830951. Office of Scientific and Technical Information, US Department of Energy, Washington, DC, 1986, pp. 116–141.
Cerveny TJ, MacVittie TJ, Young RW. Acute radiation syndrome in humans. In: Walker RI, Gerveny TJ, eds. Text Book of Military Medicine: Medical Consequences of Nuclear Warfare. TMM Publications, Office of the Surgeon General, Falls Church, VA, 1989, pp. 15–36.
Dainiak N. Hematologic consequences of exposure to ionizing radiation. Exp Hematol 2002;30:513–528.
Gusev IA, Guskova AK, Mettler FA, eds. Medical Management of Radiation Accidents. CRC Press, Boca Raton, FL, 2001.
Glasstone S, Dolan PJ, eds. The effects of Nuclear Weapons. Headquarters, Department of the Army, Washington, DC, 1977.
Blakely WF, Brooks AL, Loft RS, van der Schans GP, Voisin P. Overview of low-level radiation exposure assessment: biodosimetry. Mil Med 2002;167(suppl 1):20–24.
Wald N. Alterations of hematological parameters by radiation. In: Proceedings of Triage of Irradiated Personnel, 1998. Presented at the Armed Forces Radiobiology Research Institute Workshop, 1996, Bethesda, MD.
Bender MA, Gooch PC. Somatic chromosome aberrations induced by human whole-body irradiation: the “Recuplex” criticality accident. Radiat Res 1996;29:568–582.
Mettler FA, Upton AC. Medical Effects of Ionizing Radiation, 2nd ed. WB Saunders, Philadelphia, 1995.
Anspaugh LR, Akleyev AV, Degteva MO, Straume T, Napier BA. Interpretation of results of FISH assays when zero or only a few translocations are observed. In: Chronic Radiation Exposure: Possibilities of Biological Indication. Russian Federation, Chelyabinsk, Russia, 2000:112.
Ward JF. The complexity of DNA damage: relevance to biological consequences. Int J Radiat Biol 1994;66:427–432.
Amudson SA, Do KT, Fornace AJ. Induction of stress genes by low doses of gamma rays. Radiat Res 1999;152:225–231.
Maity A, Kao GD, Muschel RJ, McKenna WG. Potential molecular targets for manipulating the radiation response. Int J Radiat Biol Phys 1997;37:639–653.
Anderson A, Woloschak, GE. Cellular proto-oncogene expression following exposure ot mice to gamma rays. Radiat Res 1992;130:340–344.
Beetz A, Messer G, Oppel T, van Beuningen D, Peter RU, Kind P. Induction of interleukin-6 by ionizing radiation in human epithelial cell line: control by corticosteroids. Int J Radiat biol 1997;72:33–43.
Forrester HB, Yeh RF, Dewey WC. A dose response for radiation-induced intrachromosomal DNA rearrangements detected by inverse polymerase chain reaction. Radiat Res 1999;152:232–238.
Kubota N, Hayashi JI, Inada T, Iwamura Y. Induction of a particular deletion in mitochondrial DNA by X-rays depends on the inherent radiosensitivity of the cells. Radiat Res 1998;148:395–398.
MacVittie TJ, Weiss JF, Browne D. Consensus summary on the treatment of radiation injuries. In: MacVittie TJ, Weiss JF, Browne D, eds. Advances in the Treatment of Radiation Injuries. Pergamon Press, New York, 1996.
Kindler H, Densow D, Fliedner TM. Prediction of clinical course through serial determinations. In: Reeves G, Jarrett DG, Seed TM, King GL, Blakely WF, eds. Triage of Irradiated Personnel. AFRRI Special Publication 98–2. Armed Forces Radiobiology Research Institute, Bethesda, MD, 1998, pp. B6-B9.
Anno G. Fatigability and weakness as clinical indicators of exposure. In: Reeves G, Jarrett DG, Seed TM, King GL, Blakely WF, eds. Triage of Irradiated Personnel. AFRRI Special Publication 98–2. Armed Forces Radiobiology Research Institute, Bethesda, MD, 1998, pp. B12-B21.
Wald N. Alterations of hematological parameters by radiation In: Reeves G, Jarrett DG, Seed TM, King GL, Blakely WF, eds. Triage of Irradiated Personnel. AFRRI Special Publication 98–2. Armed Forces Radiobiology Research Institute, Bethesda, MD, 1998, pp. B1-B5.
Densow D, Kindler H, Baranov AE, Tibken B, Hofer EP, Fliedner TM. Criteria for the selection of radiation accident victims for stem cell transplantation. Stem Cells 1997,15(suppl 2):287–297.
Knudson GB, Elliott TB, Brook I, et al. Nuclear, biological and chemical combined injuries and countermeasures on the battlefield. Mil Med 2002;167(suppl 1):95–97.
Hubner KF, Fry SA, eds. The Medical Basis of Radiation Accident Preparedness. Elsevier, Amsterdam, 1979.
Voelz GL. Assessment and treatment of internal contamination: general principles. In: Gusev IA, Guskova AK, Mettler FA, eds. Medical Management of Radiation Accidents. CRC Press, Washington, DC, 2001, pp. 319–343.
NATO Handbook on the Medical Aspects of NBC Defense Operations AMEDP-6(B), 01 Feb. 1996.
Boxer L, Dale DC. Neutropenia: causes and consequences. Semin Hematol 2002;39:75–81.
Brook I, Elliott TB, Ledney GD, Knudson GB. Management of postirradiation sepsis: Mil Med 2002;167(suppl 1):105–106.
MacVittie TJ, Farese AM. Cytokine-based treatment of radiation injury: potentiation benefits after lowlevel radiation exposure. Mil Med 2002;167(suppl 1):68–70.
Jarrett DG. Medical Management of Radiological Casualties Handbook. Armed Forces Radiobiology Research Institute, Bethesda, MD, 1999.
Buchsel PC, Forgey A, Grape FB, Hamann SS. Granulocyte macrophage colony-stimulating factor: current practice and novel approaches. Clin J Oncol Nurs 2002;6:198–205.
Seed TM, Fry SA, Neta N, Weiss JF, Jarrett DG, Thomassen D. Prevention and treatments: summary statement. Mil Med 2002;167(suppl 1):87–93.
Chen Y, Huang X, Xu L, et al. A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases. Zhonghua Yi Xue Za Zhi 2002;82:1306–1309.
Beir V. Health effects of exposure to low levels of ionizing radiation. Committee on the Biological Effects of Ionizing Radiations, Board on Radiation Effects Research, Commission on Life Sciences. National Academy Press, Washington, DC, 1990.
Le Beau MM, Albain KS, Larson RA, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 1986;4:325–345.
Anscher MS, Kong FM, Sibley G, et al. Using plasma TGFB1 as a marker to select patients for radiotherapy dose escalation. In: Moriarty M, Motherstill C, Edington M, Ward JF, Fry RJM, eds. Radiation Research, vol 2. Proceeding of the 11th ICRR, Dublin, 1999. Allen Press, Lawrence, KS, 2000, pp. 638–640.
Nascimento PA, da Silva MA, Oliveira EM, Suzuki MF, Okazaki K. Evaluation of radioinduced damage and repair capacity in blood lymphocytes of breast cancer patients. Braz J Med Biol Res 1999;34:165–176.
Biodosimetry Assessment Tool. Armed Forces Radiobiology Research Institute, Bethesda, MD, 2002.
Blakely W, Prasanna PGS, Miller AC. Update on current and new developments in biological doseassessment techniques. In: Ricks RC, Berger ME, O’Hara FM, eds. The Medical Basis for RadiationAccident Prepareness: The Clinical Care of Victims. Parthenon Publishing Group, Washington, DC, 2001, pp. 23–32.
Peter RW, Gottlober P. Management of cutaneous radiation injuries: diagnosis and therapeutic principles of the cutaneous radiation syndrome. Mil Med 2002;167(suppl 1):110–112.
Hazard Prediction and Assessment Capability, version 4.0, program estimates, Defense Threat Reduction Agency, June 1,2001, Alexandria, VA.
Terrorism with Ionizing Radiation General Guidance: Pocket Guide, Employee Education System for the Office of Public Health Environmental Hazards. Department of Veterans Affairs, Washington, DC, 2001.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Singh, V.K., Seed, T.M. (2004). Radiation Effects. In: Roy, M.J. (eds) Physician’s Guide to Terrorist Attack. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-663-8_24
Download citation
DOI: https://doi.org/10.1007/978-1-59259-663-8_24
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9814-1
Online ISBN: 978-1-59259-663-8
eBook Packages: Springer Book Archive